Shares in Glaukos (NYSE:GKOS) have fallen today after the ophthalmic medical tech company posted first quarter earnings that saw profits swing to losses, despite topping The Street’s expectations.
The San Clemente, Calif.-based company posted losses of $2.7 million, or 8¢ per share, on sales of $40.1 million for the three months ended March 31, seeing an over 400% swing into red on the bottom-line while sales grew 11.8% compared with the same period during the previous year.
Read the whole story on our sister site, Drug Delivery Business